KANCHAN MAHON: Open Payments
NPI 1326163239 · ENDWELL, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,087 in 46 payments from 8 companies in 2025. Trend: 2023 $889 · 2024 $571 · 2025 $1,087
Food & beverage: $975Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 10 | $288 |
| E.R. Squibb & Sons, L.L.C. | 9 | $270 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $184 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $128 |
| Axsome Therapeutics, Inc. | 5 | $118 |
| Otsuka America Pharmaceutical, Inc. | 3 | $55 |
| Alkermes, Inc. | 1 | $22 |
| Lundbeck LLC | 1 | $21 |
Products named: COBENFY, CAPLYTA, AUSTEDO XR, TRINTELLIX, Auvelity, REXULTI, LYBALVI.
Industry payments across NY — which companies pay providers there.
